Presentation
8 June 2022 Development of an ACE-2 biosensor for point-of-need saliva diagnostics and surveillance of SARS-CoV-2
Author Affiliations +
Abstract
The high transmission rate and fast mutation capacity of SARS-CoV-2 requires development of low-cost/widely deployable biosensor technologies. Here, we describe the development of an enzymatic biosensor to monitor SARS-CoV-2 and its emerging variants in human saliva based. Biotinylated angiotensin converting enzyme (ACE2) was immobilized on streptavidin-coated fiber optic probes and gold chips for biolayer interferometry (BLI) and surface plasmon resonance (SPR), respectively. Kinetics of ACE2-virion binding for wild-type, Delta, UK, and South Africa variants were analyzed and compared for informing the development of a mobile detection system.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Geisianny Moreira, Lisseth Casso Hartmann, Shoumen P.A. Datta, Eric S. McLamore, and Diana Vanegas "Development of an ACE-2 biosensor for point-of-need saliva diagnostics and surveillance of SARS-CoV-2", Proc. SPIE PC12123, Smart Biomedical and Physiological Sensor Technology XIV, PC1212303 (8 June 2022); https://doi.org/10.1117/12.2622984
Advertisement
Advertisement
KEYWORDS
Biosensors

Diagnostics

Surveillance

Biological research

Fiber optics

Interferometry

Proteins

Back to Top